Back |
home / stock / coll / coll message board
Subject | By | Source | When |
---|---|---|---|
Talk about insider info/trades prior to quarterly earnings | floblu14 | investorshub | 02/28/2022 10:24:39 PM |
Collegium Pharmaceutical price target raised to $42 | floblu14 | investorshub | 02/22/2022 11:35:26 AM |
Dr. Jessica Ailani and Dr. Peter McAllister share | floblu14 | investorshub | 02/20/2022 1:17:51 AM |
Analysts' Upgrades - | floblu14 | investorshub | 02/15/2022 1:42:27 PM |
Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio | floblu14 | investorshub | 02/14/2022 11:49:15 AM |
From $COLL career posts - | floblu14 | investorshub | 02/10/2022 12:26:23 PM |
January 28, 2022 | floblu14 | investorshub | 01/28/2022 7:44:26 PM |
What does this tell you? :-) | floblu14 | investorshub | 01/19/2022 1:44:48 PM |
Best Value Pharmaceutical Stocks - 12 Jan. | floblu14 | investorshub | 01/13/2022 11:09:06 AM |
$COLL recommendation - January 3 | floblu14 | investorshub | 01/03/2022 1:25:24 PM |
We are pleased to be in a position | floblu14 | investorshub | 12/28/2021 1:49:20 PM |
Three items: | floblu14 | investorshub | 12/23/2021 2:35:47 PM |
znewcar1: COLL 25% v3,5M c25.45 f33M gap HOY@25,6 | znewcar1 | investorshangout | 02/08/2020 12:09:55 AM |
znewcar1: COLL 31% v3,5M c18. f33M H 19.97 S17.6 nice POP | znewcar1 | investorshangout | 11/07/2019 9:15:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
2024-05-30 00:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutica...
STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fi...